Филтриране по Last updated date SelectСледПредиFrom - To Дата Крайна дата This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionPRIMEProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Leave this field blank Filter Резултати (3799) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank EMA issues advice on use of Lagevrio (molnupiravir) for the treatment of COVID-19 19 November 2021NewsHumanCOVID-19Medicines EMA starts review of Paxlovid for treating patients with COVID-19 19 November 2021NewsHumanCOVID-19Medicines European Antibiotic Awareness Day: Fighting the silent pandemic 18 November 2021NewsHumanVeterinaryCorporateAntimicrobial resistance EMA receives application for marketing authorisation for Xevudy (sotrovimab) for treating patients with COVID-19 18 November 2021NewsHumanCOVID-19Medicines EMA receives application for conditional marketing authorisation of Novavax’s COVID-19 vaccine, Nuvaxovid 17 November 2021NewsHumanCOVID-19Medicines COVID-19: EMA recommends authorisation of two monoclonal antibody medicines 12 November 2021NewsHumanCOVID-19Medicines Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 8-11 November 2021 12 November 2021NewsHumanCOVID-19Medicines First-in-class medicine recommended for treatment of rare blood vessel inflammation 12 November 2021NewsHumanMedicines EMA starts evaluating use of COVID-19 vaccine Spikevax in children aged 6 to 11 10 November 2021NewsHumanCOVID-19Vaccines COVID-19: EMA and Heads of Medicines Agencies update on molnupiravir 8 November 2021NewsHumanCOVID-19Medicines 1 … 51 52 53 54 55 Page 55 of 380 56 57 58 59 … 380
EMA issues advice on use of Lagevrio (molnupiravir) for the treatment of COVID-19 19 November 2021NewsHumanCOVID-19Medicines
EMA starts review of Paxlovid for treating patients with COVID-19 19 November 2021NewsHumanCOVID-19Medicines
European Antibiotic Awareness Day: Fighting the silent pandemic 18 November 2021NewsHumanVeterinaryCorporateAntimicrobial resistance
EMA receives application for marketing authorisation for Xevudy (sotrovimab) for treating patients with COVID-19 18 November 2021NewsHumanCOVID-19Medicines
EMA receives application for conditional marketing authorisation of Novavax’s COVID-19 vaccine, Nuvaxovid 17 November 2021NewsHumanCOVID-19Medicines
COVID-19: EMA recommends authorisation of two monoclonal antibody medicines 12 November 2021NewsHumanCOVID-19Medicines
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 8-11 November 2021 12 November 2021NewsHumanCOVID-19Medicines
First-in-class medicine recommended for treatment of rare blood vessel inflammation 12 November 2021NewsHumanMedicines
EMA starts evaluating use of COVID-19 vaccine Spikevax in children aged 6 to 11 10 November 2021NewsHumanCOVID-19Vaccines
COVID-19: EMA and Heads of Medicines Agencies update on molnupiravir 8 November 2021NewsHumanCOVID-19Medicines